Pfizer

Pfizer Faces Delays In Drug Access Initiative For Low-Income Nations

Pfizer has signed agreements with less than a quarter of its targeted countries in an initiative aimed at offering not-for-profit pricing on medicines to some of the world's poorest nations. This effort, known as “An Accord for a Healthier World,” was launched in 2022 and expanded in 2023, intending to...

Study Finds Pfizer Drug Helped Cancer Patients Regain Weight

Pfizer Inc.'s experimental drug for cancer-related weight loss has shown promise in helping patients regain weight in a mid-stage study, offering hope for addressing the serious condition of muscle wasting. This condition, known as cachexia, often affects cancer patients, causing metabolic and appetite changes. It leads to the loss of...